For 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
metastatic 18 28 18 28 B-cancer
renal 29 34 29 34 I-cancer
tumors 35 41 35 41 I-cancer
to 42 44 42 44 O
be 45 47 45 47 O
enrolled 48 56 48 56 O
, 56 57 56 57 O
a 58 59 58 59 O
histologic 60 70 60 70 O
diagnosis 71 80 71 80 O
of 81 83 81 83 O
renal 84 89 84 89 B-cancer
cell 90 94 90 94 I-cancer
carcinoma 95 104 95 104 I-cancer
must 105 109 105 109 O
exist 110 115 110 115 O
and 116 119 116 119 O
any 120 123 120 123 O
burden 124 130 124 130 O
of 131 133 131 133 O
disease 134 141 134 141 O
> 142 143 142 143 O
= 143 144 143 144 O
1 145 146 145 146 B-lower_bound
cm 147 149 147 149 I-lower_bound
by 150 152 150 152 O
CT 153 155 153 155 B-treatment
or 156 158 156 158 O
MRI 159 162 159 162 B-treatment
is 163 165 163 165 O
acceptable 166 176 166 176 O
; 176 177 176 177 O
the 178 181 178 181 O
metastatic 182 192 182 192 O
sites 193 198 193 198 O
may 199 202 199 202 O
be 203 205 203 205 O
kidney 206 212 206 212 O
, 212 213 212 213 O
intra 214 219 214 219 O
- 219 220 219 220 O
abdominal 220 229 220 229 O
( 230 231 230 231 O
such 231 235 231 235 O
as 236 238 236 238 O
liver 239 244 239 244 O
) 244 245 244 245 O
, 245 246 245 246 O
brain 247 252 247 252 O
, 252 253 252 253 O
bone 254 258 254 258 O
, 258 259 258 259 O
or 260 262 260 262 O
lymph 263 268 263 268 O
nodes 269 274 269 274 O
; 274 275 274 275 O
lung 276 280 276 280 O
lesions 281 288 281 288 O
are 289 292 289 292 O
NOT 293 296 293 296 O
eligible 297 305 297 305 O
because 306 313 306 313 O
of 314 316 314 316 O
the 317 320 317 320 O
motion 321 327 321 327 O
artifact 328 336 328 336 O
caused 337 343 337 343 O
by 344 346 344 346 O
respiration 347 358 347 358 O

For 0 3 359 362 O
patients 4 12 363 371 O
with 13 17 372 376 O
organ 18 23 377 382 O
confined 24 32 383 391 O
renal 33 38 392 397 O
tumors 39 45 398 404 B-cancer
to 46 48 405 407 O
be 49 51 408 410 O
enrolled 52 60 411 419 O
, 60 61 419 420 O
the 62 65 421 424 O
renal 66 71 425 430 B-clinical_variable
mass 72 76 431 435 I-clinical_variable
must 77 81 436 440 O
be 82 84 441 443 O
> 85 86 444 445 O
= 86 87 445 446 O
1 88 89 447 448 B-lower_bound
cm 90 92 449 451 I-lower_bound
in 93 95 452 454 I-lower_bound
diameter 96 104 455 463 I-lower_bound
on 105 107 464 466 O
computed 108 116 467 475 B-treatment
tomography 117 127 476 486 I-treatment
( 128 129 487 488 I-treatment
CT 129 131 488 490 I-treatment
) 131 132 490 491 I-treatment
or 133 135 492 494 O
magnetic 136 144 495 503 B-clinical_variable
resonance 145 154 504 513 I-clinical_variable
imaging 155 162 514 521 I-clinical_variable
( 163 164 522 523 I-clinical_variable
MRI 164 167 523 526 I-clinical_variable
) 167 168 526 527 I-clinical_variable
and 169 172 528 531 O
can 173 176 532 535 O
be 177 179 536 538 O
any 180 183 539 542 O
clinical 184 192 543 551 O
stage 193 198 552 557 O
T1a 199 202 558 561 B-lower_bound
- 202 203 561 562 O
T4 203 205 562 564 B-upper_bound
( 206 207 565 566 O
non 207 210 566 569 O
- 210 211 569 570 O
metastatic 211 221 570 580 O
) 221 222 580 581 O
; 222 223 581 582 O
a 224 225 583 584 O
histologic 226 236 585 595 O
diagnosis 237 246 596 605 O
is 247 249 606 608 O
not 250 253 609 612 O
required 254 262 613 621 O
for 263 266 622 625 O
enrollment 267 277 626 636 O
; 277 278 636 637 O
the 279 282 638 641 O
primary 283 290 642 649 O
imaging 291 298 650 657 O
site 299 303 658 662 O
would 304 309 663 668 O
be 310 312 669 671 O
kidney 313 319 672 678 O

Negative 0 8 679 687 B-pregnancy
pregnancy 9 18 688 697 I-pregnancy
test 19 23 698 702 O
if 24 26 703 705 O
female 27 33 706 712 B-gender
of 34 36 713 715 O
child 37 42 716 721 O
- 42 43 721 722 O
bearing 43 50 722 729 O
age 51 54 730 733 B-age

Patients 0 8 734 742 O
with 9 13 743 747 O
metastatic 14 24 748 758 B-cancer
disease 25 32 759 766 I-cancer
may 33 36 767 770 O
have 37 41 771 775 O
received 42 50 776 784 O
prior 51 56 785 790 B-treatment
nephrectomy 57 68 791 802 I-treatment
and/or 69 75 803 809 O
prior 76 81 810 815 B-treatment
systemic 82 90 816 824 I-treatment
therapy 91 98 825 832 I-treatment
( 99 100 833 834 O
no 100 102 834 836 O
limit 103 108 837 842 O
on 109 111 843 845 O
number 112 118 846 852 O
) 118 119 852 853 O
; 119 120 853 854 O
their 121 126 855 860 O
baseline 127 135 861 869 O
pMRI 136 140 870 874 O
would 141 146 875 880 O
be 147 149 881 883 O
performed 150 159 884 893 O
prior 160 165 894 899 O
to 166 168 900 902 O
starting 169 177 903 911 O
a 178 179 912 913 O
new 180 183 914 917 O
treatment 184 193 918 927 B-treatment

Severe 0 6 928 934 O
concurrent 7 17 935 945 B-chronic_disease
disease 18 25 946 953 I-chronic_disease
, 25 26 953 954 O
infection 27 36 955 964 B-chronic_disease
, 36 37 964 965 O
or 38 40 966 968 O
medical 41 48 969 976 O
co 49 51 977 979 O
- 51 52 979 980 O
morbidity 52 61 980 989 O
that 62 66 990 994 O
, 66 67 994 995 O
in 68 70 996 998 O
the 71 74 999 1002 O
judgment 75 83 1003 1011 O
of 84 86 1012 1014 O
the 87 90 1015 1018 O
investigator 91 103 1019 1031 O
, 103 104 1031 1032 O
would 105 110 1033 1038 O
make 111 115 1039 1043 O
the 116 119 1044 1047 O
patient 120 127 1048 1055 O
inappropriate 128 141 1056 1069 O
for 142 145 1070 1073 O
enrollment 146 156 1074 1084 O

Severe 0 6 1085 1091 B-chronic_disease
renal 7 12 1092 1097 I-chronic_disease
function 13 21 1098 1106 I-chronic_disease
impairment 22 32 1107 1117 I-chronic_disease
( 33 34 1118 1119 O
estimated 34 43 1119 1128 B-clinical_variable
glomerular 44 54 1129 1139 I-clinical_variable
filtration 55 65 1140 1150 I-clinical_variable
rate 66 70 1151 1155 I-clinical_variable
[ 71 72 1156 1157 I-clinical_variable
eGFR 72 76 1157 1161 I-clinical_variable
] 76 77 1161 1162 I-clinical_variable
< 78 79 1163 1164 O
45 80 82 1165 1167 B-upper_bound
mL 83 85 1168 1170 I-upper_bound
/ 85 86 1170 1171 I-upper_bound
min/1.73 86 94 1171 1179 I-upper_bound
m^2 95 98 1180 1183 I-upper_bound
) 98 99 1183 1184 O
would 100 105 1185 1190 O
make 106 110 1191 1195 O
the 111 114 1196 1199 O
patient 115 122 1200 1207 O
inappropriate 123 136 1208 1221 O
for 137 140 1222 1225 O
enrollment 141 151 1226 1236 O
due 152 155 1237 1240 O
to 156 158 1241 1243 O
the 159 162 1244 1247 O
increased 163 172 1248 1257 O
risk 173 177 1258 1262 O
of 178 180 1263 1265 O
nephrogenic 181 192 1266 1277 B-chronic_disease
systemic 193 201 1278 1286 I-chronic_disease
fibrosis 202 210 1287 1295 I-chronic_disease
( 211 212 1296 1297 I-chronic_disease
NSF 212 215 1297 1300 I-chronic_disease
) 215 216 1300 1301 I-chronic_disease
with 217 221 1302 1306 O
higher 222 228 1307 1313 O
dose 229 233 1314 1318 O
of 234 236 1319 1321 O
IV 237 239 1322 1324 B-treatment
gadolinium 240 250 1325 1335 I-treatment
- 250 251 1335 1336 I-treatment
based 251 256 1336 1341 I-treatment
contrast 257 265 1342 1350 I-treatment
agents 266 272 1351 1357 I-treatment
( 273 274 1358 1359 I-treatment
GBCA 274 278 1359 1363 I-treatment
) 278 279 1363 1364 I-treatment
administration 280 294 1365 1379 O

Subjects 0 8 1380 1388 O
who 9 12 1389 1392 O
are 13 16 1393 1396 O
unable 17 23 1397 1403 O
to 24 26 1404 1406 O
tolerate 27 35 1407 1415 O
or 36 38 1416 1418 O
are 39 42 1419 1422 O
not 43 46 1423 1426 O
eligible 47 55 1427 1435 O
for 56 59 1436 1439 O
MR 60 62 1440 1442 O
imaging 63 70 1443 1450 O
( 71 72 1451 1452 O
claustrophobia 72 86 1452 1466 B-chronic_disease
, 86 87 1466 1467 O
metal 88 93 1468 1473 O
implantable 94 105 1474 1485 O
devices 106 113 1486 1493 O
such 114 118 1494 1498 O
as 119 121 1499 1501 O
pacemaker 122 131 1502 1511 B-treatment
, 131 132 1511 1512 O
aneurysm 133 141 1513 1521 B-treatment
clips 142 147 1522 1527 I-treatment
, 147 148 1527 1528 O
etc 149 152 1529 1532 O
) 152 153 1532 1533 O

Subjects 0 8 1534 1542 O
with 9 13 1543 1547 O
established 14 25 1548 1559 O
allergy 26 33 1560 1567 O
to 34 36 1568 1570 O
IV 37 39 1571 1573 B-allergy_name
GBCA 40 44 1574 1578 I-allergy_name

Women 0 5 1579 1584 B-gender
who 6 9 1585 1588 O
are 10 13 1589 1592 B-pregnancy
pregnant 14 22 1593 1601 I-pregnancy

